These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 30734500)
21. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies. Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408 [TBL] [Abstract][Full Text] [Related]
22. A cure for HIV: is it in sight? Pace M; Frater J Expert Rev Anti Infect Ther; 2014 Jul; 12(7):783-91. PubMed ID: 24745361 [TBL] [Abstract][Full Text] [Related]
23. Lipid Nanocarriers for Anti-HIV Therapeutics: A Focus on Physicochemical Properties and Biotechnological Advances. Faria MJ; Lopes CM; das Neves J; Lúcio M Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452255 [TBL] [Abstract][Full Text] [Related]
24. Implications of prioritizing HIV cure: new momentum to overcome old challenges in HIV. Tucker JD; Gilbertson A; Lo YR; Vitória M BMC Infect Dis; 2016 Mar; 16():109. PubMed ID: 26939697 [TBL] [Abstract][Full Text] [Related]
25. HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide? Kulpa DA; Chomont N J Virus Erad; 2015 Apr; 1(2):59-66. PubMed ID: 26448966 [TBL] [Abstract][Full Text] [Related]
26. The role of integration and clonal expansion in HIV infection: live long and prosper. Anderson EM; Maldarelli F Retrovirology; 2018 Oct; 15(1):71. PubMed ID: 30352600 [TBL] [Abstract][Full Text] [Related]
27. Introduction: challenges to finding a cure for HIV infection. Richman DD Curr Opin HIV AIDS; 2011 Jan; 6(1):1-3. PubMed ID: 21242886 [TBL] [Abstract][Full Text] [Related]
28. A Systematic Review of the Inclusion (or Exclusion) of Women in HIV Research: From Clinical Studies of Antiretrovirals and Vaccines to Cure Strategies. Curno MJ; Rossi S; Hodges-Mameletzis I; Johnston R; Price MA; Heidari S J Acquir Immune Defic Syndr; 2016 Feb; 71(2):181-8. PubMed ID: 26361171 [TBL] [Abstract][Full Text] [Related]
29. Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection. Agbosu EE; Ledger S; Kelleher AD; Wen J; Ahlenstiel CL Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890248 [TBL] [Abstract][Full Text] [Related]
30. New Frontiers in Measuring and Characterizing the HIV Reservoir. Falcinelli SD; Ceriani C; Margolis DM; Archin NM Front Microbiol; 2019; 10():2878. PubMed ID: 31921056 [TBL] [Abstract][Full Text] [Related]
31. Antigen-driven clonal selection shapes the persistence of HIV-1-infected CD4+ T cells in vivo. Simonetti FR; Zhang H; Soroosh GP; Duan J; Rhodehouse K; Hill AL; Beg SA; McCormick K; Raymond HE; Nobles CL; Everett JK; Kwon KJ; White JA; Lai J; Margolick JB; Hoh R; Deeks SG; Bushman FD; Siliciano JD; Siliciano RF J Clin Invest; 2021 Feb; 131(3):. PubMed ID: 33301425 [TBL] [Abstract][Full Text] [Related]
32. Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies. Ta TM; Malik S; Anderson EM; Jones AD; Perchik J; Freylikh M; Sardo L; Klase ZA; Izumi T Front Microbiol; 2022; 13():862270. PubMed ID: 35572626 [TBL] [Abstract][Full Text] [Related]
33. HIV - Is a cure possible? Sankaranantham M Indian J Sex Transm Dis AIDS; 2019; 40(1):1-5. PubMed ID: 31143852 [TBL] [Abstract][Full Text] [Related]
34. Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology. Mylvaganam G; Yanez AG; Maus M; Walker BD Front Immunol; 2019; 10():2109. PubMed ID: 31552045 [TBL] [Abstract][Full Text] [Related]
35. Insights from Clonal Expansion and HIV Persistence in Perinatal Infections. Dhummakupt A; Persaud D mBio; 2021 Aug; 12(4):e0098321. PubMed ID: 34425702 [TBL] [Abstract][Full Text] [Related]
36. HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective. Sarmati L; D'Ettorre G; Parisi SG; Andreoni M Curr HIV Res; 2015; 13(3):250-7. PubMed ID: 25845389 [TBL] [Abstract][Full Text] [Related]
37. Pharmacology of HIV Cure: Site of Action. Devanathan AS; Cottrell ML Clin Pharmacol Ther; 2021 Apr; 109(4):841-855. PubMed ID: 33540481 [TBL] [Abstract][Full Text] [Related]
38. Controversies in the Design of Strategies for the Cure of HIV Infection. de Gea-Grela A; Moreno S Pathogens; 2023 Feb; 12(2):. PubMed ID: 36839593 [TBL] [Abstract][Full Text] [Related]
39. Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1. Bertagnolli LN; Varriale J; Sweet S; Brockhurst J; Simonetti FR; White J; Beg S; Lynn K; Mounzer K; Frank I; Tebas P; Bar KJ; Montaner LJ; Siliciano RF; Siliciano JD Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32066-32077. PubMed ID: 33239444 [TBL] [Abstract][Full Text] [Related]
40. Continuous Prophylactic Antiretrovirals/Antiretroviral Therapy Since Birth Reduces Seeding and Persistence of the Viral Reservoir in Children Vertically Infected With Human Immunodeficiency Virus. Massanella M; Puthanakit T; Leyre L; Jupimai T; Sawangsinth P; de Souza M; Suntarattiwong P; Kosalarksa P; Borkird T; Kanjanavanit S; Chokephaibulkit K; Hansudewechakul R; Petdachai W; Mitchell JL; Robb ML; Trautmann L; Ananworanich J; Chomont N; Clin Infect Dis; 2021 Aug; 73(3):427-438. PubMed ID: 32504081 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]